LabGenomics Co., Ltd. (KOSDAQ:084650)
1,759.00
-57.00 (-3.14%)
Jan 30, 2026, 3:30 PM KST
LabGenomics Revenue
LabGenomics had revenue of 23.04B KRW in the quarter ending September 30, 2025, with 6.43% growth. This brings the company's revenue in the last twelve months to 89.36B, up 6.71% year-over-year. In the year 2024, LabGenomics had annual revenue of 85.90B with 20.85% growth.
Revenue (ttm)
89.36B
Revenue Growth
+6.71%
P/S Ratio
1.51
Revenue / Employee
629.32M
Employees
142
Market Cap
134.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 85.90B | 14.82B | 20.85% |
| Dec 31, 2023 | 71.08B | -73.70B | -50.90% |
| Dec 31, 2022 | 144.77B | -57.63B | -28.47% |
| Dec 31, 2021 | 202.41B | 82.93B | 69.41% |
| Dec 31, 2020 | 119.48B | 86.30B | 260.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB bioStep | 71.47B |
| C&R Research | 63.97B |
| DreamCIS | 62.06B |
| DT&CRO CO. | 44.36B |
| WOOJUNG BIO | 37.12B |
| P&K Skin Research Center | 22.13B |
| BioInfra | 21.92B |
| Hyundai ADM Bio | 9.74B |